From the National Center for Advancing Translational Sciences
From the National Institutes of Health
Workshop on Merkel Cell Carcinoma: Basic, Epidemiologic, Translational and Clinical Research
Friday, January 09, 2009
National Institutes of Health Neurosciences Center, Rooms A1/A2, Rockville, MD
Approaches to deal with the rarity of Merkel cell carcinoma (MCC) were identified. Meeting participants tried to reach consensus on research gaps and priorities within three broadly defined disciplines. It was hoped that the intersections of these two types of outcome would result a series of research protocols.
Contact: Dr. James J. Goedert, NCI 301-435-4724
National Cancer Institute